Clinical Physiology of Circulation

ISSN 1814-6910 (Print)
ISSN 2410-9134 (Online)

 

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Issue's catalogue ➤ КФК. 2023; 20 (Cпецвыпуск): 1-53 ➤ Эпидемиология хронической венозной недостаточности, факторы риска и симптоматика развития трофических расстройств

Epidemiology of chronic venous insufficiency, risk factors and symptoms of development of trophic disorders

Authors: Malinin A.A.1, Chomaeva A.A.2, Bagyan A.R.1, Argunova S.Sh.3

Company:
1 Bakoulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russian Federation
2 Treatment and Rehabilitation Center, Cherkessk, Russian Federation
3 Karachay-Cherkessia Republican Clinical Hospital, Cherkessk, Russian Federation

E-mail: Сведения доступны для зарегистрированных пользователей.

DOI: https://doi.org/10.24022/1814-6910-2023-20S1-18-26

UDC: 616.14-009.85

Link: Clinical Physiology of Blood Circulaiton. 2023; Спецвыпуск (20): 18-26

Quote as: Malinin A.A., Chomaeva A.A., Bagyan A.R, Argunova S.Sh. Epidemiology of chronic venous insufficiency, risk factors and symptoms of development of trophic disorders. Clinical Physiology of Circulation. 2023; 20 (Special Issue 1): 18–26 (in Russ.). DOI: 10.24022/1814-6910-2023-20S1-18-26

Keywords:  chronic venous diseases chronic venous insufficiency trophic venous ulcers symptoms of trophic disorders

Received / Accepted:  23.09.2023 / 20.10.2023

Download
Full text:  

Abstract

The review analyzes works devoted to the epidemiology of chronic venous insufficiency (CVI) in the stage of trophic disorders, as well as risk factors and prevalence of clinical manifestations. The work is aimed at informing practicing physicians about the frequency of occurrence of venous trophic disorders, which by etiology are caused by the consequences of deep vein thrombosis or severe forms of varicose disease. Trophic venous disorders worsen the quality of life of patients and are not only a medical but also a socio-economic problem, and in some cases lead to patient disability. Trophic venous ulcers in post-thrombotic disease are often recurrent and require constant treatment and drug provision. All age groups of both sexes are at risk of developing post-thrombotic disease, and their frequency increases with age. The strategy for preventing the development of post-thrombotic disease consists in the timely administration of anticoagulant and phlebological therapy in the treatment of deep vein thrombosis.

References

  1. O’Donnell T.F. Venous ulcers of the lower extremity: etiology, risks, and predictive factors. Chapter 3. In: Cynthia K. Shortell, Jovan N. Markovic (Eds.) Venous ulcers. 2nd ed. Academic Press; 2023: 41–62. DOI: 10.1016/B978-0-323-90610-4.00014-8
  2. Gujja K., Kayiti T., Sanina C., Wiley J.M. Chronic venous insufficiency. In: Dangas G.D., Mario C.Di, Thiele H., Barlis P. (Eds.). Interventional cardiology: principles and practice. 3rd ed. Wiley-Blackwell; 2022: 835–843.
  3. Salim S., Machin M., Patterson B.O., Onida S., Davies A.H. Global epidemiology of chronic venous disease: a systematic review with pooled prevalence analysis. Ann. Surg. 2021; 274 (6): 971–976. DOI: 10.1097/SLA.0000000000004631
  4. Илюхин Е.А., Абрамова С.А., Вербицкий Н.С., Воронин М.С., Герасимова Д.Е., Камардин Ф.И. и др. Многоцентровое проспективное наблюдательное исследование по оценке приверженности пациентов с хронической венозной недостаточностью терапии сулодексидом в условиях рутинной амбулаторной практики ALLEGRO. Флебология. 2020; 14 (2): 74–82. DOI: 10.17116/flebo20201402174
  5. Максимов М.Л., Ермолаева А.С., Вознесенская А.А., Стародубцев А.К. Хронические заболевания вен: особенности патогенеза и рациональные подходы к терапии. РМЖ «Медицинское обозрение». 2018; 4: 25–29.
  6. Кириенко А.И., Золотухин И.А., Юмин С.М., Селиверстов Е.И. Эффективность специализированной флебологической помощи в России: результаты проспективного обсервационного исследования СПЕКТР. Флебология. 2015; 9 (2): 4–11. DOI: 10.17116/ flebo2015924-11
  7. Kolluri R., Lugli M., Villalba L., Varcoe R., Maleti O., Gallardo F. et al. An estimate of the economic burden of venous leg ulcers associated with deep venous disease. Vasc. Med. 2022; 27: 63–72. DOI: 10.1177/1358863X211028298 Erratum in: Vasc. Med. 2022; 27: NP1 DOI: 10.1177/1358863X211048020
  8. Ortega M.A., Fraile-Martínez O., García-Montero C., Álvarez-Mon M.A., Chaowen C., Ruiz-Grande F. et al. Understanding chronic venous disease: a critical overview of its pathophysiology and medical management. J. Clin. Med. 2021; 10: 3239. DOI: 10.3390/jcm10153239
  9. Голухова Е.З. Отчет о научной и лечебной работе Национального медицинского исследовательского центра сердечно-сосудистой хирургии им. А.Н. Бакулева Минздрава России за 2021 год и перспективы развития. Сердечно-сосудистые заболевания. Бюллетень НЦССХ им. А.Н. Бакулева РАМН. 2022; спецвыпуск (23): 12–111. DOI: 10.24022/1810-0694-2022-23S
  10. Karetová D., Chochola M., Vaskulární medicína. Praha: Maxdorf; 2018: 340–351 (in Czech).
  11. Ngatchou W., Barche B., Temgoua M., Metouguena S.E., Jutcha I., Mvondo C.M. et al. Prevalence, clinical presentation, and risk factors of chronic venous disease in Cameroon: a general population-based study. Phlebology. 2024; 39 (4): 259–66. DOI: 10.1177/02683555231224111
  12. Kahn S.R., Comerota A.J., Cushman M., Evans N.S., Ginsberg J.S., Goldenberg N.A. et al. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies. Circulation. 2014; 130 (18): 1636–1661. DOI: 10.1161/CIR.0000000000000130
  13. Markovic J.N., Taormina M.V., Dillavou E.D. The diagnosis of major venous outflow obstruction in chronic venous insufficiency. Chapter 7. In: Cynthia K. Shortell, Jovan N. Markovic (Eds.) Venous ulcers. 2nd ed. Academic Press; 2023: 41–62. DOI: 10.1016/B978-0-323-90610- 4.00028-8
  14. Carman T.L., Al-Omari A. Evaluation and management of chronic venous disease using the foundation of CEAP. Curr. Cardiol. Rep. 2019; 21 (10): 114. DOI: 10.1007/s11886-019-1201-1
  15. Galanaud J.P., Monreal M., Kahn, S.R. Epidemiology of the post-thrombotic syndrome. Thromb. Res. 2018; 164: 100–109. DOI: 10.1016/j. thromres.2017.07.026
  16. Zolotukhin I.A., Seliverstov E.I., Shevtsov Y.N., Avakiants I.P., Nikishkov A.S., Tatarintsev A.M., Kirienko A.I. Prevalence and risk factors for chronic venous disease in the general Russian population. Eur. J. Vasc. Endovasc. Surg. 2017; 54: 752–758. DOI: 10.1016/j.ejvs.2017.08.033
  17. Голухова Е.З. Результаты научной и лечебной работы Национального медицинского исследовательского центра сердечно-сосудистой хирургии им. А.Н. Бакулева Минздрава Роcсии за 2020 год и перспективы развития. Сердечно-сосудистые заболевания. Бюллетень НЦССХ им. А.Н. Бакулева РАМН. 2021; 22 (Спецвыпуск). DOI: 10.24022/1810-0694-2021-22S
  18. Jarošíková R., Roztočil K., Husáková J., Dubský M., Robert B.É.M. et al. Chronic venous disease and its intersections with diabetes mellitus. Physiol. Res. 2023; 72 (3): 280–286. DOI: 10.33549/physiolres.935033
  19. Шанаев И.Н. Современные представления о механизмах развития варикозной и посттромботической болезней. Кубанский научный медицинский вестник. 2020; 27 (1): 105–125. DOI: 10.25207/1608-6228-2020-27-1-105-125
  20. Escudero Rodriguez J.R., Fernandez Quesada F., Bellmunt Montoya S. Prevalence and clinical characteristics of chronic venous disease in patients seen in primary care in Spain: results of the international study Vein Consult Program. Cir. Esp. 2014; 92 (8): 539–546. DOI: 10.1016/j. ciresp.2013.09.013
  21. Rabe E., Pannier F. Epidemiology of chronic venous disorders. In: Gloviczki P., Dalsing M.C., Ekloef B. et al. (Eds.). Handbook of venous and lymphatic disorders: Guidelines of the American Venous Forum. 4th ed. CRC Press; 2017: 121–127.
  22. Peddamallu S.K.R., Koilakonda A.K., Appaji K.K.S. A study of chronic superficial venous insufficiency in patients with competent saphenofemoral junction. Int. Surg J. 2022; 9 (11): 1826–1829. DOI: 10.18203/2349-2902.isj20222646
  23. Rajey N., Pathak B., Bhatia S., Singh R.P. A prospective study on the treatment of chronic non-healing ulcers using autologous platelet rich plasma. Eur. J. Mol. Clin. Med. 2022; 9 (3): 9945–9953.
  24. Kreft D., Keiler J., Grambow E., Kischkel S., Wree A., Doblhammer G. Prevalence and mortality of venous leg diseases of the deep veins: an observational cohort study based on German health claims data. Angiology. 2020; 71 (5): 452–464. DOI: 10.1177/0003319720905751
  25. Дубровщик О.И., Довнар И.С., Колешко С.В., Ясюк Л.С., Ясюк А.А. Трофические язвы венозного генеза: современные возможности лечения. Журнал Гродненского государственного медицинского университета. 2016; 2 (54): 107–111.
  26. Савинов И.С., Ильченко Ф.Н., Бутырский А.Г., Савинов С.Г., Матвеева Н.В., Калачев Е.В. Оценка эффективности и ближайших результатов эндовенозной лазерной коагуляции в комплексном лечении тяжелых форм варикозной болезни. Вестник Волгоградского государственного медицинского университета. 2017; 64 (4): 41–45.
  27. Аралова М.В., Остроушко А.П. Распространенность венозных трофических язв нижних конечностей у жителей воронежской области. Вестник экспериментальной и клинической хирургии. 2015; 8 (2): 248–251.
  28. Шутов Ю.М., Шумков О.А., Верятин Я.А. Субульцерозное влияние обогащенной тромбоцитами аутоплазмы в сочетании с регионарной лимфостимуляцией на заживление хронических венозных язв голени. Медицина. Социология. Философия. Прикладные исследования. 2023; 1: 28–34.
  29. Мазайшвили К., Дарвин В. Компрессионная терапия заболеваний вен нижних конечностей. Литрес; 2022.
  30. Васин В.И., Ступин В.А., Корейба К.А., Ягжина В.Е., Сенина Е.Р., Селюто В.В., Силина Е.В. К вопросу об эпидемиологии и лечении острых и хронических ран. Современная наука: актуальные проблемы теории и практики. Серия: Естественные и технические науки. 2021; 4 (2): 70.
  31. Главнов П.В., Варзин С.А. Современные возможности хирурга в диагностике и лечении трофических язв венозной этиологии (обзор литературы). Вестник Санкт-Петербургского университета. Медицина. 2022; 17 (3): 175–190.
  32. Pradier M., Rodger M.A., Ghanima W., Kovacs M.J., Shivakumar S., Kahn S.R., Delluc A. Performance and head-to head comparison of three clinical models to predict occurrence of post-thrombotic syndrome: a validation study. Thromb. Haemost. 2023; 123 (7): 692–699. DOI: 10.1055/a-2039-3388
  33. Кузьмин Ю.В., Жидков С.А., Кикоин Г.С. Трофические нарушения и подходы к их лечению при хронической венозной недостаточности нижних конечностей. Военная медицина. 2022; 3: 100–106. DOI: 10.51922/2074-5044.2022.3.100
  34. Almeida I.L.G.I.D., Figueiredo P.H.S., Silva W.T., Mendonça V.A., Lacerda A.C.R., Lima V.P., Costa H.S. Reliability and validity of specific quality of life assessment questionnaires related to chronic venous insufficiency: a systematic review. J. Vasc. Bras. 2022; 21: e20210229. DOI: 10.1590/1677-5449.202102292
  35. Li R., Yuan M., Cheng J., Yu Sh., Wei W., Fu W. et al. Risk of postthrombotic syndrome after deep vein thrombosis treated with rivaroxaban versus vitamin-K antagonists: a systematic review and meta-analysis. Thromb. Res. 2020; 196: 340–348. DOI: 10.1016/j.thromres.2020.09.014
  36. Karathanos C., Giannoukas A. Role of anticoagulation treatment in the prevention of post-thrombotic syndrome. Phlebolymphology. 2022; 29(2): 60–65.
  37. Alsheef M.A., Alabbad A.M., Albassam R.A., Alarfaj R.M., Zaidi A.R.Z., Alarfaj O.A., Abu-Shaheen A. Predictors of pregnancy-associated venous thromboembolism: a case-control study. Front. Cardiovasc. Med. 2022; 9: 920089. DOI: 10.3389/fcvm.2022.920089
  38. Голухова Е.З., Ярустовский М.Б., Сокольская Н.О., Кокшенев И.В., Папиташвили В.Г. Итоги работы XXIV Ежегодной сессии ФГБУ «НМИЦ ССХ им. А.Н. Бакулева» Минздрава России с Всероссийской конференцией молодых ученых, посвященной 65-летию со дня основания Центра. Сердечно-сосудистые заболевания. Бюллетень НЦССХ им. А.Н. Бакулева РАМН. 2022; 1 (23): 141–157. DOI: 10.24022/1810-0694-2022-23-1-141-157
  39. Гришин И.Н., Подгайский В.Н., Старосветская И.С. Варикоз и варикозная болезнь нижних конечностей. Минск: Вышэйшая школа; 2005.
  40. Смирнова Е.С., Васильев И.М., Богданец Л.И., Андрияшкин В.В. Результаты лечения трофических язв у больных с варикозной болезнью нижних конечностей. Хирург. 2015; 9: 52–62.
  41. Беликов Д.В., Улаева Е.А., Королёва Е.В. Возможности оптимизации лечения больных трофическими язвами венозной этиологии. Международный журнал экспериментального образования. 2015; 6: 54.
  42. Westin G.G., Maijub J.G., Dalsing M.C. Treatment modalities for the management of nonhealing wounds in patients with chronic venous insufficiency. Chapter 16. in: Cynthia K. Shortell, Jovan N. Markovic (Eds.) Venous ulcers. 2nd ed. Academic Press; 2023: 283–296. DOI: 10.1016/B978-0-323-90610-4.00026-4
  43. Bergqvist D. Thromboprophylaxis. The SAGES/ERAS® Society Manual of Enhanced Recovery Programs for Gastrointestinal Surgery. Springer; 2015: 97–103.
  44. De Oliveira Viana Pereira D.M., de Souza Oliveira A.C., de Oliveira Júnior S.A., Jacinto M.A.G., Dionísio A.J., Lima A.E.O., de Vasconcelos Torres G. Correlation between generic and disease-specific quality of life questionnaires in patients with venous ulcerations: a cross-sectional study carried out in a primary health care setting in Brazil. Int. J. Envir. Res. Publ. Health. 2023; 20 (4): 3583.
  45. De Angelis B., Orlandi F., Morais D’Autilio M. F. L., Di Segni C., Scioli M. G., Orlandi A., Gentile P. Vasculogenic chronic ulcer: tissue regeneration with an innovative dermal substitute. J. Clin. Med. 2019; 8 (4): 525.
  46. Sridharan M., Ashrani A.A. Presentation and significance of venous thromboembolism. In: Chaar C. (Ed.) Current management of venous diseases. Springer, Cham; 2018: 245–263. DOI: 10.1007/978-3-319-65226-9_19
  47. Pompilio G., Nicolaides A., Kakkos S.K., Integlia D. Systematic literature review and network Meta-analysis of sulodexide and other drugs in chronic venous disease. Phlebology. 2021; 36 (9): 695–709.
  48. Schulman S., Lindmarker P., Holmstrom M., Larfars G., Carlsson A., Nicol P. et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J. Thromb. Haemost. 2006; 4: 734–742.
  49. Maida V., Shi R.B., Fazzari F.G.T., Zomparelli L. Topical cannabis‐based medicines – A novel adjuvant treatment for venous leg ulcers: An open‐label trial. Exp. Derm. 2021; 30 (9): 1258–1267.
  50. Vuylsteke M.E., Thomis S., Guillaume G., Modliszewski M.L., Weides N., Staelens I. Epidemiological study on chronic venous disease in Belgium and Luxembourg: prevalence, risk factors, and symptomatology. Eur. J. Vasc. Endovasc. Surg. 2015; 49 (4): 432–439. DOI: 10.1016/j. ejvs.2014.12.031
  51. Nelzén O. Venous ulcers of the lower extremity: epidemiology and socio-economic burden. Chapter 4. In: Cynthia K. Shortell, Jovan N. Markovic (Eds.) Venous ulcers. 2nd ed. Academic Press; 2023; 63–81.
  52. Mosti G., Caggiati A. Improving treatment outcomes – management of coexisting comorbidities in patients with venous ulcers. Chapter 18. In: Cynthia K. Shortell, Jovan N. Markovic (Eds.) Venous ulcers. 2nd ed. Academic Press; 2023; 315–325.
  53. Stanek A., Mosti G., Nematillaevich T.S., Valesky E.M., Planinšek Ručigaj T., Boucelma M., Marakomichelakis G. et al. No more venous ulcers – what more can we do? J. Clin. Med. 2023; 12 (19): 6153. DOI: 10.3390/jcm12196153
  54. Mahlapuu M., Sidorowicz A., Mikosinski J., Krzyżanowski M., Orleanski J., Twardowska‐Saucha K., Apelqvist J. Evaluation of LL‐37 in healing of hard‐to‐heal venous leg ulcers: a multicentric prospective randomized placebo‐controlled clinical trial. Wound Rep. Reg. 2021; 29(6): 938–950.
  55. Franks P.J., Barker J., Collier M., Gethin G., Haesler E., Jawien, A., Weller C. Management of patients with venous leg ulcers: challenges and current best practice. J. Wound Care. 2016; 25 (Sup. 6): S1–S67.
  56. Ratliff C.R., Yates S., McNichol L., Gray M. Compression for primary prevention, treatment, and prevention of recurrence of venous leg ulcers: an evidence-and consensus-based algorithm for care across the continuum. J. Wound Ost. Cont. Nurs. 2016; 43 (4): 347.
  57. Mervis J.S., Kirsner R.S., Lev-Tov H. Protocol for a longitudinal cohort study: determination of risk factors for the development of first venous leg ulcer in people with chronic venous insufficiency, the VEINS (venous insufficiency in South Florida) cohort. BMJ Open. 2019; 9(1): e023313.
  58. Meulendijks A.M., de Vries F.M.C., van Dooren A.A., Schuurmans M.J., Neumann H.A.M. A systematic review on risk factors in developing a first‐time Venous Leg Ulcer. J. Eur. Acad. Dermatol. Venereol. 2019; 33 (7): 1241–1248.
  59. Орлов И.Н. Результаты лечебной работы Института коронарной и сосудистой хирургии НМИЦ ССХ им. А.Н. Бакулева Минздрава России в 2021 г. Сердечно-сосудистые заболевания. Бюллетень НЦССХ им. А.Н. Бакулева РАМН. 2022; 2 (23): 275–283. DOI: 10.24022/1810-0694-2022-23-2-275-283
****
  1. O’Donnell T.F. Venous ulcers of the lower extremity: etiology, risks, and predictive factors. Chapter 3. In: Cynthia K. Shortell, Jovan N. Markovic (Eds.) Venous ulcers. 2nd ed. Academic Press; 2023: 41–62. DOI: 10.1016/B978-0-323-90610-4.00014-8
  2. Gujja K., Kayiti T., Sanina C., Wiley J.M. Chronic venous insufficiency. In: Dangas G.D., Mario C.Di, Thiele H., Barlis P. (Eds.). Interventional cardiology: principles and practice. 3rd ed. Wiley-Blackwell; 2022: 835–843.
  3. Salim S., Machin M., Patterson B.O., Onida S., Davies A.H. Global epidemiology of chronic venous disease: a systematic review with pooled prevalence analysis. Ann. Surg. 2021; 274 (6): 971–976. DOI: 10.1097/SLA.0000000000004631
  4. Ilyukhin E.A., Abramova S.A., Verbitsky N.S., Voronin M.S., Gerasimova D.E., Kamardin F.I. et al. Multiple-center prospective observational trial on assessment of the compliance of patients with chronic venous insufficiency to sulodexide therapy in routine outpatient practice ALLEGRO. Flebologiya. 2020; 14 (2): 74–82 (in Russ.). DOI: 10.17116/flebo20201402174
  5. Maksimov M.L., Ermolaeva A.S., Voznesenskaya A.A., Starodubtsev A.K. Chronic venous diseases: features of pathogenesis and rational approaches to therapy. RMJ. Medical Review. 2018; 4: 25–29 (in Russ.).
  6. Kirienko A.I., Zolotukhin I.A., Iumin S.M., Seliverstov E.I. Efficiency of specialized phlebological care in Russia: results of the prospective observational study SPECTRUM. Phlebology. 2015; 9 (2): 4–11. DOI: 10.17116/flebo2015924-11
  7. Kolluri R., Lugli M., Villalba L., Varcoe R., Maleti O., Gallardo F. et al. An estimate of the economic burden of venous leg ulcers associated with deep venous disease. Vasc. Med. 2022; 27: 63–72. DOI: 10.1177/1358863X211028298 Erratum in: Vasc. Med. 2022; 27: NP1 DOI: 10.1177/1358863X211048020
  8. Ortega M.A., Fraile-Martínez O., García-Montero C., Álvarez-Mon M.A., Chaowen C., Ruiz-Grande F. et al. Understanding chronic venous disease: a critical overview of its pathophysiology and medical management. J. Clin. Med. 2021; 10: 3239. DOI: 10.3390/jcm10153239
  9. Golukhova E.Z. Report on the scientific and clinical activity of Bakoulev National Medical Research Center for Cardiovascular Surgery for 2021 and development prospects. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2022; 23 (Special Issue) (in Russ.). DOI: 10.24022/1810-0694-2022-23S
  10. Karetová D., Chochola M., Vaskulární medicína. Praha: Maxdorf; 2018: 340–351 (in Czech).
  11. Ngatchou W., Barche B., Temgoua M., Metouguena S.E., Jutcha I., Mvondo C.M. et al. Prevalence, clinical presentation, and risk factors of chronic venous disease in Cameroon: a general population-based study. Phlebology. 2024; 39 (4): 259–66. DOI: 10.1177/02683555231224111
  12. Kahn S.R., Comerota A.J., Cushman M., Evans N.S., Ginsberg J.S., Goldenberg N.A. et al. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies. Circulation. 2014; 130 (18): 1636–1661. DOI: 10.1161/CIR.0000000000000130
  13. Markovic J.N., Taormina M.V., Dillavou E.D. The diagnosis of major venous outflow obstruction in chronic venous insufficiency. Chapter 7. In: Cynthia K. Shortell, Jovan N. Markovic (Eds.) Venous ulcers. 2nd ed. Academic Press; 2023: 41–62. DOI: 10.1016/B978-0-323-90610- 4.00028-8
  14. Carman T.L., Al-Omari A. Evaluation and management of chronic venous disease using the foundation of CEAP. Curr. Cardiol. Rep. 2019; 21 (10): 114. DOI: 10.1007/s11886-019-1201-1
  15. Galanaud J.P., Monreal M., Kahn, S.R. Epidemiology of the post-thrombotic syndrome. Thromb. Res. 2018; 164: 100–109. DOI: 10.1016/j. thromres.2017.07.026
  16. Zolotukhin I.A., Seliverstov E.I., Shevtsov Y.N., Avakiants I.P., Nikishkov A.S., Tatarintsev A.M., Kirienko A.I. Prevalence and risk factors for chronic venous disease in the general Russian population. Eur. J. Vasc. Endovasc. Surg. 2017; 54: 752–758. DOI: 10.1016/j.ejvs.2017.08.033
  17. Golukhova E.Z. The results of scientific and clinical activities of Bakoulev National Medical Research Center for Cardiovascular Surgery in 2020 and development prospects. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2021; 22 (Special Issue) (in Russ.). DOI: 10.24022/1810-0694-2021-22S
  18. Jarošíková R., Roztočil K., Husáková J., Dubský M., Robert B.É.M. et al. Chronic venous disease and its intersections with diabetes mellitus. Physiol. Res. 2023; 72 (3): 280–286. DOI: 10.33549/physiolres.935033
  19. Shanaev I.N. Modern views on the development of varicose and post-thrombotic diseases. Kuban Scientific Medical Bulletin. 2020; 27 (1): 105–125 (in Russ.). DOI: 10.25207/1608-6228-2020-27-1-105-125
  20. Escudero Rodriguez J.R., Fernandez Quesada F., Bellmunt Montoya S. Prevalence and clinical characteristics of chronic venous disease in patients seen in primary care in Spain: results of the international study Vein Consult Program. Cir. Esp. 2014; 92 (8): 539–546. DOI: 10.1016/j. ciresp.2013.09.013
  21. Rabe E., Pannier F. Epidemiology of chronic venous disorders. In: Gloviczki P., Dalsing M.C., Ekloef B. et al. (Eds.). Handbook of venous and lymphatic disorders: Guidelines of the American Venous Forum. 4th ed. CRC Press; 2017: 121–127.
  22. Peddamallu S.K.R., Koilakonda A.K., Appaji K.K.S. A study of chronic superficial venous insufficiency in patients with competent saphenofemoral junction. Int. Surg J. 2022; 9 (11): 1826–1829. DOI: 10.18203/2349-2902.isj20222646
  23. Rajey N., Pathak B., Bhatia S., Singh R.P. A prospective study on the treatment of chronic non-healing ulcers using autologous platelet rich plasma. Eur. J. Mol. Clin. Med. 2022; 9 (3): 9945–9953.
  24. Kreft D., Keiler J., Grambow E., Kischkel S., Wree A., Doblhammer G. Prevalence and mortality of venous leg diseases of the deep veins: an observational cohort study based on German health claims data. Angiology. 2020; 71 (5): 452–464. DOI: 10.1177/0003319720905751
  25. Dubrovshchik O.I., Dovnar I.S., Koleshko S.V., Yasyuk L.S., Yasyuk A.A. Trophic ulcers of venous genesis: modern treatment options. Journal of Grodno State Medical University. 2016; 2 (54): 107–111 (in Russ.).
  26. Savinov I.S., Ilchenko F.N., Butyrskiy A.G., Savinov S.G., Matveeva N.V., Kalachev E.V. Evaluation of the effectiveness and immediate results of endovenous laser coagulation in the complex treatment of severe forms of varicose veins. Bulletin of the Volgograd State Medical University. 2017; 64 (4): 41–45 (in Russ.).
  27. Aralova M.V., Ostroushko A.P. Prevalence of venous trophic ulcers of the lower extremities in residents of the Voronezh region. Bulletin of Experimental and Clinical Surgery. 2015; 8 (2): 248–251 (in Russ.).
  28. Shutov Yu.M., Shumkov O.A., Veryatin Ya.A. Subulcerous effect of platelet-rich autoplasma in combination with regional lymphostimulation on the healing of chronic venous leg ulcers. Medicine. Sociology. Philosophy. Applied Research. 2023; 1: 28–34 (in Russ.).
  29. Mazajshvili K., Darvin V. Compression therapy of lower extremity venous diseases. Litres; 2022 (in Russ.).
  30. Vasin V.I., Stupin V.A., Korejba K.A., Yagzhina V.E., Senina E.R., Selyuto V.V., Silina E.V. On the issue of epidemiology and treatment of acute and chronic wounds. Modern Science: Current Problems of Theory and Practice. Series: Natural and Technical Sciences. 2021; 4 (2): 70 (in Russ.).
  31. Glavnov P.V., Varzin S.A. Modern capabilities of a surgeon in the diagnosis and treatment of trophic ulcers of venous etiology (literature review). Bulletin of St. Petersburg University. Medicine. 2022; 17 (3): 175–190 (in Russ.).
  32. Pradier M., Rodger M.A., Ghanima W., Kovacs M.J., Shivakumar S., Kahn S.R., Delluc A. Performance and head-to head comparison of three clinical models to predict occurrence of post-thrombotic syndrome: a validation study. Thromb. Haemost. 2023; 123 (7): 692–699. DOI: 10.1055/a-2039-3388
  33. Kuzmin Yu.V., Zhidkov S.A., Kikoin G.S. Trophic disorders and approaches to their treatment in chronic venous insufficiency of the lower extremities. Military Medicine. 2022; 3: 100–106 (in Russ.). DOI: 10.51922/2074-5044.2022.3.100
  34. Almeida I.L.G.I.D., Figueiredo P.H.S., Silva W.T., Mendonça V.A., Lacerda A.C.R., Lima V.P., Costa H.S. Reliability and validity of specific quality of life assessment questionnaires related to chronic venous insufficiency: a systematic review. J. Vasc. Bras. 2022; 21: e20210229. DOI: 10.1590/1677-5449.202102292
  35. Li R., Yuan M., Cheng J., Yu Sh., Wei W., Fu W. et al. Risk of postthrombotic syndrome after deep vein thrombosis treated with rivaroxaban versus vitamin-K antagonists: a systematic review and meta-analysis. Thromb. Res. 2020; 196: 340–348. DOI: 10.1016/j.thromres.2020.09.014
  36. Karathanos C., Giannoukas A. Role of anticoagulation treatment in the prevention of post-thrombotic syndrome. Phlebolymphology. 2022; 29(2): 60–65.
  37. Alsheef M.A., Alabbad A.M., Albassam R.A., Alarfaj R.M., Zaidi A.R.Z., Alarfaj O.A., Abu-Shaheen A. Predictors of pregnancy-associated venous thromboembolism: a case-control study. Front. Cardiovasc. Med. 2022; 9: 920089. DOI: 10.3389/fcvm.2022.920089
  38. Golukhova E.Z., Yarustovskiy M.B., Sokolskaya N.O., Kokshenev I.V., Papitashvili V.G. Results of the XXIV Annual Session of the A.N. Bakulev National Medical Research Center for Cardiovascular Surgery of the Ministry of Health of the Russian Federation with the All- Russian Conference of Young Scientists dedicated to the 65th anniversary of the founding of the Center. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2022; 1 (23): 141–157 (in Russ.). DOI: 10.24022/1810-0694-2022-23-1-141-157
  39. Grishin I.N., Podgayskiy V.N., Starosvetskaya I.S. Varicose veins and varicose disease of the lower extremities. Minsk; 2005 (in Russ.).
  40. Smirnova E.S., Vasilyev I.M., Bogdanets L.I., Andriyashkin V.V. Results of treatment of trophic ulcers in patients with varicose veins of the lower extremities. Surgeon. 2015; 9: 52–62 (in Russ.).
  41. Belikov D.V., Ulaeva E.A., Korolyova E.V. Possibilities of optimizing treatment of patients with trophic ulcers of venous etiology.International Journal of Experimental Education. 2015; 6: 54 (in Russ.).
  42. Westin G.G., Maijub J.G., Dalsing M.C. Treatment modalities for the management of nonhealing wounds in patients with chronic venous insufficiency. Chapter 16. in: Cynthia K. Shortell, Jovan N. Markovic (Eds.) Venous ulcers. 2nd ed. Academic Press; 2023: 283–296. DOI: 10.1016/B978-0-323-90610-4.00026-4
  43. Bergqvist D. Thromboprophylaxis. The SAGES/ERAS® Society Manual of Enhanced Recovery Programs for Gastrointestinal Surgery. Springer; 2015: 97–103.
  44. De Oliveira Viana Pereira D.M., de Souza Oliveira A.C., de Oliveira Júnior S.A., Jacinto M.A.G., Dionísio A.J., Lima A.E.O., de Vasconcelos Torres G. Correlation between generic and disease-specific quality of life questionnaires in patients with venous ulcerations: a cross-sectional study carried out in a primary health care setting in Brazil. Int. J. Envir. Res. Publ. Health. 2023; 20 (4): 3583.
  45. De Angelis B., Orlandi F., Morais D’Autilio M. F. L., Di Segni C., Scioli M. G., Orlandi A., Gentile P. Vasculogenic chronic ulcer: tissue regeneration with an innovative dermal substitute. J. Clin. Med. 2019; 8 (4): 525.
  46. Sridharan M., Ashrani A.A. Presentation and significance of venous thromboembolism. In: Chaar C. (Ed.) Current management of venous diseases. Springer, Cham; 2018: 245–263. DOI: 10.1007/978-3-319-65226-9_19
  47. Pompilio G., Nicolaides A., Kakkos S.K., Integlia D. Systematic literature review and network Meta-analysis of sulodexide and other drugs in chronic venous disease. Phlebology. 2021; 36 (9): 695–709.
  48. Schulman S., Lindmarker P., Holmstrom M., Larfars G., Carlsson A., Nicol P. et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J. Thromb. Haemost. 2006; 4: 734–742.
  49. Maida V., Shi R.B., Fazzari F.G.T., Zomparelli L. Topical cannabis‐based medicines – A novel adjuvant treatment for venous leg ulcers: An open‐label trial. Exp. Derm. 2021; 30 (9): 1258–1267.
  50. Vuylsteke M.E., Thomis S., Guillaume G., Modliszewski M.L., Weides N., Staelens I. Epidemiological study on chronic venous disease in Belgium and Luxembourg: prevalence, risk factors, and symptomatology. Eur. J. Vasc. Endovasc. Surg. 2015; 49 (4): 432–439. DOI: 10.1016/j. ejvs.2014.12.031
  51. Nelzén O. Venous ulcers of the lower extremity: epidemiology and socio-economic burden. Chapter 4. In: Cynthia K. Shortell, Jovan N. Markovic (Eds.) Venous ulcers. 2nd ed. Academic Press; 2023; 63–81.
  52. Mosti G., Caggiati A. Improving treatment outcomes – management of coexisting comorbidities in patients with venous ulcers. Chapter 18. In: Cynthia K. Shortell, Jovan N. Markovic (Eds.) Venous ulcers. 2nd ed. Academic Press; 2023; 315–325.
  53. Stanek A., Mosti G., Nematillaevich T.S., Valesky E.M., Planinšek Ručigaj T., Boucelma M., Marakomichelakis G. et al. No more venous ulcers – what more can we do? J. Clin. Med. 2023; 12 (19): 6153. DOI: 10.3390/jcm12196153
  54. Mahlapuu M., Sidorowicz A., Mikosinski J., Krzyżanowski M., Orleanski J., Twardowska‐Saucha K., Apelqvist J. Evaluation of LL‐37 in healing of hard‐to‐heal venous leg ulcers: a multicentric prospective randomized placebo‐controlled clinical trial. Wound Rep. Reg. 2021; 29(6): 938–950.
  55. Franks P.J., Barker J., Collier M., Gethin G., Haesler E., Jawien, A., Weller C. Management of patients with venous leg ulcers: challenges and current best practice. J. Wound Care. 2016; 25 (Sup. 6): S1–S67.
  56. Ratliff C.R., Yates S., McNichol L., Gray M. Compression for primary prevention, treatment, and prevention of recurrence of venous leg ulcers: an evidence-and consensus-based algorithm for care across the continuum. J. Wound Ost. Cont. Nurs. 2016; 43 (4): 347.
  57. Mervis J.S., Kirsner R.S., Lev-Tov H. Protocol for a longitudinal cohort study: determination of risk factors for the development of first venous leg ulcer in people with chronic venous insufficiency, the VEINS (venous insufficiency in South Florida) cohort. BMJ Open. 2019; 9(1): e023313.
  58. Meulendijks A.M., de Vries F.M.C., van Dooren A.A., Schuurmans M.J., Neumann H.A.M. A systematic review on risk factors in developing a first‐time Venous Leg Ulcer. J. Eur. Acad. Dermatol. Venereol. 2019; 33 (7): 1241–1248.
  59. Orlov I.N. Results of the medical work of the Institute of Coronary and Vascular Surgery of the A.N. Bakulev National Medical Research Center of Cardiovascular Surgery of the Ministry of Health of the Russian Federation in 2021. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2022; 2 (23): 275–283 (in Russ.). DOI: 10.24022/1810-0694-2022-23-2-275-283

About Authors

  • Aleksandr A. Malinin, Dr. Med. Sci., Chief Researcher; ORCID
  • Aida A. Chomaeva, Cand. Med. Sci., Cardiovascular Surgeon; ORCID
  • Arut R. Bagyan, Postgraduate; ORCID
  • Svetlana Sh. Argunova, Cardiovascular Surgeon; ORCID

 If you found mistakes, select text and press Alt+A